[{"address1": "1405 St. Paul Street", "address2": "Suite 201", "city": "Kelowna", "state": "BC", "zip": "V1Y 9N2", "country": "Canada", "phone": "877 255 4337", "website": "https://allied.health", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Allied Corp., a cannabis company, engages in the research, development, and production of cannabinoid health solutions in the United States. The company offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. It also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand. In addition, the company offers Skin Structure, a facial formula applied to enhance skin; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds for areas with inflammation, pain, and other skin ailments under the MaXXa brand. Further, it is developing ALID 10 and ALID 11, which is in Phase I clinical trial a pharma product for the treatment of post-traumatic stress disorder and related mental health conditions. The company is headquartered in Kelowna, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Calum  Hughes Ph.D.", "title": "Founder, Chairman & CEO", "fiscalYear": 2023, "totalPay": 112311, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Marschaalk B.Sc., C.P.A.", "title": "Chief Financial Officer", "fiscalYear": 2023, "totalPay": 84249, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Bullock", "title": "COO & Director", "fiscalYear": 2023, "totalPay": 93592, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Santiago  Ribero", "title": "VP of Corporate Development, Director of LATAM Corporate & Director", "fiscalYear": 2023, "totalPay": 45900, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Smeeding M.B.A., MBA, R.Ph., RPh", "age": 73, "title": "VP of Pharmaceuticals Development & Director", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 60000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Moses", "title": "Chief Business Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Radka  Milanova Ph.D.", "title": "Chief Scientific Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.069, "open": 0.05, "dayLow": 0.0411, "dayHigh": 0.069, "regularMarketPreviousClose": 0.069, "regularMarketOpen": 0.05, "regularMarketDayLow": 0.0411, "regularMarketDayHigh": 0.069, "beta": -0.182, "volume": 86904, "regularMarketVolume": 86904, "averageVolume": 17635, "averageVolume10days": 42638, "averageDailyVolume10Day": 42638, "marketCap": 6192054, "fiftyTwoWeekLow": 0.0211, "fiftyTwoWeekHigh": 0.31713, "priceToSalesTrailing12Months": 287.86862, "fiftyDayAverage": 0.0671026, "twoHundredDayAverage": 0.1541082, "currency": "USD", "enterpriseValue": 12131511, "floatShares": 65782375, "sharesOutstanding": 101843000, "heldPercentInsiders": 0.5107, "heldPercentInstitutions": 4.0000003e-05, "bookValue": -0.071, "lastFiscalYearEnd": 1693440000, "nextFiscalYearEnd": 1725062400, "mostRecentQuarter": 1701302400, "netIncomeToCommon": -10202803, "trailingEps": -0.11, "lastSplitFactor": "6:1", "lastSplitDate": 1565136000, "enterpriseToRevenue": 563.994, "enterpriseToEbitda": -1.332, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ALID", "underlyingSymbol": "ALID", "shortName": "ALLIED CORP", "longName": "Allied Corp.", "firstTradeDateEpochUtc": 1565875800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4fc55e69-684d-36dc-83e2-d343b0be9733", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0608, "recommendationKey": "none", "totalCash": 39594, "ebitda": -9109241, "totalDebt": 5979056, "quickRatio": 0.021, "currentRatio": 0.05, "totalRevenue": 21510, "returnOnAssets": -1.45947, "freeCashflow": -1483549, "operatingCashflow": -1827302, "revenueGrowth": -0.727, "operatingMargins": -35.37376, "financialCurrency": "USD", "trailingPegRatio": null}]